ΠΠΎΠΌΠ°ΡΠ½Ρ ΡΡΠΎΡΡΠ½ΠΊΠ°B1AX34 β’ BVMF
add
Baxter ΠnternatΡonal
ΠΠ°ΠΊΡΠΈΡΡΡ ΠΏΠΎΠΏΠ΅Ρ. Π΄Π½Ρ
81,75Β R$
ΠΡΠ°ΠΏΠ°Π·ΠΎΠ½ ΡΡΠ½ Π·Π° ΡΡΠΊ
80,31Β R$ - 108,85Β R$
Π ΠΈΠ½ΠΊΠΎΠ²Π° ΠΊΠ°ΠΏΡΡΠ°Π»ΡΠ·Π°ΡΡΡ
15,39Β ΠΌΠ»ΡΠ΄ USD
Π‘Π΅Ρ. ΠΎΠ±ΡΡΠ³
11,00
Π£ Π½ΠΎΠ²ΠΈΠ½Π°Ρ
Π€ΡΠ½Π°Π½ΡΠΎΠ²Ρ Π΄Π°Π½Ρ
ΠΠ²ΡΡ ΠΏΡΠΎ ΡΡΠ½Π°Π½ΡΠΎΠ²Ρ ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠΈ
ΠΠΎΡ
ΡΠ΄
Π§ΠΈΡΡΠΈΠΉ Π΄ΠΎΡ
ΡΠ΄
(USD) | Π±Π΅Ρ. 2025β―Ρ.info | ΠΠΌΡΠ½Π° Π·Π° ΡΡΠΊ |
---|---|---|
ΠΠΎΡ
ΡΠ΄ | 2,62Β ΠΌΠ»ΡΠ΄ | 5,42% |
ΠΠΏΠ΅ΡΠ°ΡΡΠΉΠ½Ρ Π²ΠΈΡΡΠ°ΡΠΈ | 732,00Β ΠΌΠ»Π½ | -9,85% |
Π§ΠΈΡΡΠΈΠΉ Π΄ΠΎΡ
ΡΠ΄ | 126,00Β ΠΌΠ»Π½ | 240,54% |
ΠΠ°ΡΠΆΠ° ΡΠΈΡΡΠΎΠ³ΠΎ ΠΏΡΠΈΠ±ΡΡΠΊΡ | 4,80 | 222,15% |
ΠΡΠΈΠ±ΡΡΠΎΠΊ Π½Π° Π°ΠΊΡΡΡ | 0,55 | -15,38% |
EBITDA | 503,00Β ΠΌΠ»Π½ | 16,17% |
ΠΡΠ΅ΠΊΡΠΈΠ²Π½Π° ΡΡΠ°Π²ΠΊΠ° ΠΏΠΎΠ΄Π°ΡΠΊΡ | 2Β 233,33% | β |
ΠΡΡ
Π³Π°Π»ΡΠ΅ΡΡΡΠΊΠΈΠΉ Π±Π°Π»Π°Π½Ρ
ΠΠ°Π³Π°Π»ΡΠ½Π° Π²Π°ΡΡΡΡΡΡ Π°ΠΊΡΠΈΠ²ΡΠ²
ΠΠ°Π³Π°Π»ΡΠ½Π° ΡΡΠΌΠ° Π·ΠΎΠ±ΠΎΠ²βΡΠ·Π°Π½Ρ
(USD) | Π±Π΅Ρ. 2025β―Ρ.info | ΠΠΌΡΠ½Π° Π·Π° ΡΡΠΊ |
---|---|---|
ΠΠΎΡΡΠ²ΠΊΠΎΠ²Ρ ΠΉ ΠΊΠΎΡΠΎΡΠΊΠΎΡΡΡΠΎΠΊΠΎΠ²Ρ Π²ΠΊΠ»Π°Π΄ΠΈ | 2,29Β ΠΌΠ»ΡΠ΄ | -24,19% |
ΠΠ°Π³Π°Π»ΡΠ½Π° Π²Π°ΡΡΡΡΡΡ Π°ΠΊΡΠΈΠ²ΡΠ² | 21,30Β ΠΌΠ»ΡΠ΄ | -23,33% |
ΠΠ°Π³Π°Π»ΡΠ½Π° ΡΡΠΌΠ° Π·ΠΎΠ±ΠΎΠ²βΡΠ·Π°Π½Ρ | 14,25Β ΠΌΠ»ΡΠ΄ | -27,12% |
ΠΠ°Π³. ΡΡΠΌΠ° Π²Π»Π°ΡΠ½. ΠΊΠ°ΠΏΡΡΠ°Π»Ρ | 7,05Β ΠΌΠ»ΡΠ΄ | β |
Π¦ΠΈΡΠΊΡΠ»ΡΡΡΡ Π°ΠΊΡΡΡ | 513,17Β ΠΌΠ»Π½ | β |
P/B ΠΊΠΎΠ΅ΡΡΡΡΡΠ½Ρ | 5,92 | β |
Π Π΅Π½ΡΠ°Π±Π΅Π»ΡΠ½ΡΡΡΡ Π°ΠΊΡΠΈΠ²ΡΠ² | 2,72% | β |
Π Π΅Π½ΡΠ°Π±Π΅Π»ΡΠ½ΡΡΡΡ ΠΊΠ°ΠΏΡΡΠ°Π»Ρ | 3,38% | β |
ΠΡΠΎΡΠΎΠ²ΠΈΠΉ ΠΏΠΎΡΡΠΊ
Π§ΠΈΡΡΠ° Π·ΠΌΡΠ½Π° Π·Π°Π»ΠΈΡΠΊΡ Π³ΠΎΡΡΠ²ΠΊΠΈ
(USD) | Π±Π΅Ρ. 2025β―Ρ.info | ΠΠΌΡΠ½Π° Π·Π° ΡΡΠΊ |
---|---|---|
Π§ΠΈΡΡΠΈΠΉ Π΄ΠΎΡ
ΡΠ΄ | 126,00Β ΠΌΠ»Π½ | 240,54% |
ΠΠΎΡΡΠ²ΠΊΠ° Π²ΡΠ΄ ΠΎΠΏΠ΅ΡΠ°ΡΡΠΉ | -193,00Β ΠΌΠ»Π½ | -218,40% |
ΠΠΎΡΡΠ²ΠΊΠ° Π²ΡΠ΄ ΡΠ½Π²Π΅ΡΡΠΈΡΡΠΉ | 3,26Β ΠΌΠ»ΡΠ΄ | 2Β 066,87% |
ΠΠΎΡΡΠ²ΠΊΠ° Π²ΡΠ΄ ΡΡΠ½Π°Π½ΡΡΠ²Π°Π½Π½Ρ | -3,23Β ΠΌΠ»ΡΠ΄ | -2Β 204,29% |
Π§ΠΈΡΡΠ° Π·ΠΌΡΠ½Π° Π·Π°Π»ΠΈΡΠΊΡ Π³ΠΎΡΡΠ²ΠΊΠΈ | -118,00Β ΠΌΠ»Π½ | 29,76% |
ΠΡΠ»ΡΠ½ΠΈΠΉ Π³ΡΠΎΡΠΎΠ²ΠΈΠΉ ΠΏΠΎΡΡΠΊ | 1,73Β ΠΌΠ»ΡΠ΄ | 395,14% |
ΠΠ½ΡΠΎΡΠΌΠ°ΡΡΡ
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
The company primarily focuses on products to treat chronic and acute medical conditions. The company had 2023 global net sales of $14.8 billion, across three business: "Medical Product and Therapies", "Healthcare Systems and Technologies" and Pharmaceuticals.
Baxter's Medical Product and Therapies business comprise two divisions: the first named "Advanced Surgery" that produce technologies to enhance surgeons' technique, increase efficiencies and improve outcomes. The second named "Infusion Therapies and Technologies" produces intravenous products and other products used in the delivery of fluids and drugs to patients.
Baxter's Healthcare System and Technologies business has four divisions "Front Line Care", "Digital Platform and Innovations", "Care and Connectivity Solutions" and "Global Services".
Baxter's Pharmaceuticals business produce inhalational anaesthetics and other differentiated hospital pharmaceuticals in areas of pain, critical care, anti-infection and oncology. Wikipedia
ΠΠ΅Π½Π΅ΡΠ°Π»ΡΠ½ΠΈΠΉ Π΄ΠΈΡΠ΅ΠΊΡΠΎΡ
ΠΠ°ΡΠ° Π·Π°ΡΠ½ΡΠ²Π°Π½Π½Ρ
1931
ΠΠΎΠ»ΠΎΠ²Π½ΠΈΠΉ ΠΎΡΡΡ
ΠΠ΅Π±-ΡΠ°ΠΉΡ
ΠΡΠ»ΡΠΊΡΡΡΡ ΠΏΡΠ°ΡΡΠ²Π½ΠΈΠΊΡΠ²
38Β 000